Cargando…
Molecular docking, synthesis and biological evaluation of Vascular Endothelial Growth Factor (VEGF) B based peptide as antiangiogenic agent targeting the second domain of the Vascular Endothelial Growth Factor Receptor 1 (VEGFR1D2) for anticancer application
Autores principales: | Sadremomtaz, Afsaneh, Ali, Ameena M., Jouyandeh, Foroozan, Balalaie, Saeed, Navari, Razieh, Broussy, Sylvain, Mansouri, Kamran, Groves, Matthew R., Asghari, S. Mohsen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7272640/ https://www.ncbi.nlm.nih.gov/pubmed/32499505 http://dx.doi.org/10.1038/s41392-020-0177-z |
Ejemplares similares
-
Impact of vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptor (VEGFR) single nucleotide polymorphisms on outcome in gastroenteropancreatic neuroendocrine neoplasms
por: Berardi, Rossana, et al.
Publicado: (2018) -
Molecular Targeting of Epidermal Growth Factor Receptor (EGFR) and Vascular Endothelial Growth Factor Receptor (VEGFR)
por: Kaufman, Nichole E. M., et al.
Publicado: (2021) -
Rational Design of Antiangiogenic Helical Oligopeptides Targeting the Vascular Endothelial Growth Factor Receptors
por: Zanella, Simone, et al.
Publicado: (2019) -
Vascular Endothelial Growth Factor A and VEGFR-1 Change during Preimplantation in Heifers
por: Chiumia, Daniel, et al.
Publicado: (2020) -
A Structural Overview of Vascular Endothelial Growth Factors Pharmacological Ligands: From Macromolecules to Designed Peptidomimetics
por: Ye, Xiaoqing, et al.
Publicado: (2021)